219 related articles for article (PubMed ID: 20337816)
21. Initial experience with routine administration of etanercept in psoriasis.
de Groot M; Appelman M; Spuls PI; de Rie MA; Bos JD
Br J Dermatol; 2006 Oct; 155(4):808-14. PubMed ID: 16965432
[TBL] [Abstract][Full Text] [Related]
22. Case reports of etanercept in inflammatory dermatoses.
Norman R; Greenberg RG; Jackson JM
J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S139-42. PubMed ID: 16488329
[TBL] [Abstract][Full Text] [Related]
23. Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study.
Gisondi P; Cotena C; Tessari G; Girolomoni G
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):341-4. PubMed ID: 18005022
[TBL] [Abstract][Full Text] [Related]
24. Etanercept: new preparation. Useful after methotrexate failure in inflammatory rheumatism.
Prescrire Int; 2003 Aug; 12(66):127-32. PubMed ID: 12906020
[TBL] [Abstract][Full Text] [Related]
25. Etanercept for the treatment of psoriasis.
Bissonnette R
Skin Therapy Lett; 2006 Feb; 11(1):1-4. PubMed ID: 16485060
[TBL] [Abstract][Full Text] [Related]
26. Combination therapy to treat moderate to severe psoriasis.
Lebwohl M; Menter A; Koo J; Feldman SR
J Am Acad Dermatol; 2004 Mar; 50(3):416-30. PubMed ID: 14988684
[TBL] [Abstract][Full Text] [Related]
27. Etanercept in psoriasis treatment.
Pietrzak A; Chodorowska G; Urban J; Roliński J; Pietrzak B
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):222-6. PubMed ID: 15314989
[TBL] [Abstract][Full Text] [Related]
28. Treatment of moderate-to-severe plaque psoriasis.
Salgo R; Thaçi D
G Ital Dermatol Venereol; 2009 Dec; 144(6):701-11. PubMed ID: 19907408
[TBL] [Abstract][Full Text] [Related]
29. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Mola EM; Pedersen R; Freundlich B; Chang DJ;
Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331
[TBL] [Abstract][Full Text] [Related]
30. Childhood psoriasis.
Dogra S; Kaur I
Indian J Dermatol Venereol Leprol; 2010; 76(4):357-65. PubMed ID: 20657115
[TBL] [Abstract][Full Text] [Related]
31. Etanercept: efficacy and safety.
Jiménez-Puya R; Gómez-García F; Amorrich-Campos V; Moreno-Giménez JC
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):402-5. PubMed ID: 19210697
[TBL] [Abstract][Full Text] [Related]
32. Cessation of cyclosporine therapy by treatment with etanercept in patients with severe psoriasis.
Yamauchi PS; Lowe NJ
J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S135-8. PubMed ID: 16488328
[No Abstract] [Full Text] [Related]
33. Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis.
Bansback NJ; Ara R; Barkham N; Brennan A; Fraser AD; Conway P; Reynolds A; Emery P
Rheumatology (Oxford); 2006 Aug; 45(8):1029-38. PubMed ID: 16782734
[TBL] [Abstract][Full Text] [Related]
34. Etanercept, a tumour necrosis factor alpha receptor antagonist, and methotrexate in acute sensorineural hearing loss.
Street I; Jobanputra P; Proops DW
J Laryngol Otol; 2006 Dec; 120(12):1064-6. PubMed ID: 17040588
[TBL] [Abstract][Full Text] [Related]
35. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
Katz HI
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
[TBL] [Abstract][Full Text] [Related]
36. Exacerbation of paranoid schizophrenia in a psoriatic patient after treatment with cyclosporine A, but not with etanercept.
Di Nuzzo S; Zanni M; De Panfilis G
J Drugs Dermatol; 2007 Oct; 6(10):1046-7. PubMed ID: 17966184
[TBL] [Abstract][Full Text] [Related]
37. Methotrexate and ciclosporin combination for the treatment of severe psoriasis.
Aydin F; Canturk T; Senturk N; Turanli AY
Clin Exp Dermatol; 2006 Jul; 31(4):520-4. PubMed ID: 16716153
[TBL] [Abstract][Full Text] [Related]
38. Etanercept in arthritis.
Scott DL
Int J Clin Pract; 2005 Jan; 59(1):114-8. PubMed ID: 15707475
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of etanercept in an integrated multistudy database of patients with psoriasis.
Gordon K; Korman N; Frankel E; Wang H; Jahreis A; Zitnik R; Chang T
J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S101-11. PubMed ID: 16488320
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
Uhlenhake EE; Feldman SR
Expert Opin Biol Ther; 2010 Jul; 10(7):1105-12. PubMed ID: 20446825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
